Showing results (1801-1810 of 2,036) with videos related to

Sort By:
Pageof 204
Frontiers in Antibiotics|June 6, 2025
Inclusion of patient-centered, non-microbiological endpoints and biomarkers in tuberculosis drug trialsAndrew R DiNardo, Wilbert Sabiiti, Stephen H Gillespie, et al.
Proceedings. Biological Sciences|October 17, 2023
Coral larval settlement induction using tissue-associated and exuded coralline algae metabolites and the identification of putative chemical cuesZachary A Quinlan, Matthew-James Bennett, Milou G I Arts, et al.
JAMA Network Open|December 9, 2021
Effectiveness of an Annular Closure Device to Prevent Recurrent Lumbar Disc Herniation: A Secondary Analysis With 5 Years of Follow-upClaudius Thomé, Adisa Kuršumovic, Peter Douglas Klassen, et al.
Nature Communications|October 29, 2021
Congenital disorder of glycosylation caused by starting site-specific variant in syntaxin-5Peter T A Linders, Eveline C F Gerretsen, Angel Ashikov, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 12, 2017
Bacillus Calmette-Guérin vaccination at birth and in vitro cytokine responses to non-specific stimulation. A randomized clinical trialT N Nissen, N M Birk, B A Blok, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 13, 2020
Central radiology assessment of the randomized phase III open-label OVHIPEC-1 trial in ovarian cancerSimone N Koole, Leigh Bruijs, Cristina Fabris, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 10, 2018
Colorectal premalignancy is associated with consensus molecular subtypes 1 and 2K Chang, J A Willis, J Reumers, et al.
Ebiomedicine|July 16, 2026
Ribavirin post-exposure prophylaxis for Andes virus exposure: a viewpointRoger J Brüggemann, Albert Vollaard, Sacha de Stoppelaar, et al.
JAMA|July 18, 2008
Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: a randomized controlled trialLianne C Krab, Arja de Goede-Bolder, Femke K Aarsen, et al.
The Analyst|August 6, 1999
Multi-laboratory study of the analysis and kinetics of stanozolol and its metabolites in treated calvesH F De Brabander, K De Wasch, L A van Ginkel, et al.
Pageof 204